Join the #BLUEBALLOONCHALLENGE
For every post, Medtronic will donate 5€ to Life for a Child
Want to take part? Simply share a video or photo of yourself keeping a blue balloon in the air on LinkedIn or Instagram using the #BlueBalloonChallenge.
Don’t have a Blue Balloon? No problem simply use our virtual photo booth to join the challenge and activate a donation.
Our Solutions and Services
Automated Self-adjusting insulin pump
The MiniMed™ 780G System automatically adjusts insulin delivery to help more patients reach glycaemic targets with less effort1,2,3,4 and no fingersticks*.
Advanced diabetes technology for MDI users
The Smart MDI system combines InPen™ smart insulin pen + Simplera™ CGM to automatically record real-time glucose trends, insulin dosing data, track active insulin, and calculate mealtime and correction boluses.
The Smart MDI System. Together, the Guardian 4™ System and InPen™ Smart** Insulin Pen System help your patients to stay ahead of their glucose levels***5,6.
Education & Services
Discover how you can develop your expertise with our blended learning offering and find out more about the range of patient services, complementing the care you offer them.
CareLink™ system - Data Management Software
Optimise patient outcomes. The portfolio of Carelink™ software reports can identify trends, track daily activities and help you identify patterns and behaviour which may be affecting a patients diabetes management.
Redefining life with Diabetes
For more than 35 years, Medtronic Diabetes has committed to drive innovation, including new insulin delivery solutions that make life easier by reducing the burden of diabetes and deliver strong clinical outcomes.
- Carlson AL, et al. Poster # 97 at the 80th International Conference of the American Diabetes Association, June 2020, Chicago/Virtual.
- Medtronic data on file: Pivotal Trial (Age 14-75). N=157. 16 US sites; 2020.
- Battelino T, et al. Diabetes Care 2019; 42(8): 1593-1603.
- ADA Guidelines of A1C<7.0 – www.Diabetes.org
- Abraham SB, et al. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts. Journal of Diabetes Science and Technology 2021; 15(1):91–97
- Smith M, et al, E5 , SIPs Improve Time Below Range in MDI Therapy, AMCP Congress 2020
